Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
10.82
-0.11 (-1.01%)
Jul 30, 2026, 11:16 AM EDT - Market open
Ardent Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,551 | 1,261 | 2,438 | - | - | - | |
Market Cap Growth | 1.72% | -48.26% | - | - | - | - |
Enterprise Value | 3,246 | 3,213 | 4,508 | 0 | 0 | 0 |
Last Close Price | 10.82 | 8.83 | 17.08 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.48 | 9.20 | 10.81 | - | - | - |
Forward PE | 9.96 | 6.83 | 8.79 | - | - | - |
PEG Ratio | 2.49 | 3.84 | 0.12 | - | - | - |
PS Ratio | 0.24 | 0.20 | 0.41 | - | - | - |
PB Ratio | 1.17 | 0.98 | 2.16 | - | - | - |
P/TBV Ratio | 4.15 | 3.91 | 11.20 | - | - | - |
P/FCF Ratio | 7.19 | 4.88 | 19.12 | - | - | - |
P/OCF Ratio | 3.60 | 2.68 | 7.74 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.50 | 0.51 | 0.76 | - | - | - |
EV/EBITDA Ratio | 6.47 | 6.68 | 8.17 | - | - | - |
EV/EBIT Ratio | 9.56 | 9.87 | 11.11 | - | - | - |
EV/FCF Ratio | 14.89 | 12.43 | 35.35 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.30 | 1.33 | 1.46 | 2.16 | 2.22 | - |
Debt / EBITDA Ratio | 4.55 | 4.71 | 4.05 | 6.45 | 6.61 | - |
Debt / FCF Ratio | 10.49 | 8.76 | 17.53 | 27.93 | - | - |
Net Debt / Equity Ratio | 1.25 | 1.21 | 1.48 | 2.86 | 2.96 | - |
Net Debt / EBITDA Ratio | 3.34 | 3.23 | 3.04 | 5.25 | 5.32 | - |
Net Debt / FCF Ratio | 7.69 | 6.01 | 13.17 | 22.74 | -9.97 | - |
Asset Turnover | 1.22 | 1.23 | 1.23 | 1.17 | 2.29 | - |
Inventory Turnover | 84.03 | 42.22 | 42.30 | 40.99 | 76.59 | - |
Quick Ratio | 1.36 | 1.33 | 1.37 | 1.22 | 1.31 | - |
Current Ratio | 2.12 | 1.97 | 1.94 | 1.63 | 1.74 | - |
Return on Equity (ROE) | 13.45% | 14.35% | 23.01% | 12.10% | 50.53% | - |
Return on Assets (ROA) | -3.53% | 5.11% | 6.92% | 4.14% | 8.26% | - |
Return on Invested Capital (ROIC) | -5.59% | 8.13% | 10.80% | 6.43% | 6.29% | - |
Return on Capital Employed (ROCE) | 7.94% | 7.89% | 10.47% | 6.06% | 11.83% | - |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.57% | 10.87% | 9.25% | - | - | - |
FCF Yield | 13.91% | 20.50% | 5.23% | - | - | - |
Payout Ratio | - | 0.00% | 0.00% | 0.00% | 92.54% | 40.27% |
Buyback Yield / Dilution | -3.91% | -6.56% | -5.26% | 0.00% | 73.80% | -1.59% |
Total Shareholder Return | -3.91% | -6.56% | -5.26% | 0.00% | 73.80% | -1.59% |